Charles E. Boyk Law Offices, LLC
The FDA has issued reports that indicate patients that use the SGLT2 Inhibitors for diabetes are at serious risk for contracting what is known as diabetic ketoacidosis. When this has developed, it means that the patient has too much acid in their blood.
Patients should be aware of the symptoms for diabetic ketoacidosis, which commonly include strained breathing, muscle stiffness, abdominal pain, vomiting, confusion, unquenchable thirst, nausea, rapid weight loss, as well as unusual sleepiness and fatigue.
The FDA reports also show that many patients that had taken the SGLT2 Inhibitors developed urinary tract infections, which later developed into life-threatening infections of the blood and kidney. Further, the FDA published a warning of additional complications such as bone loss and fractures.
Sodium-glucose co-transporter-2 (SGLT2 Inhibitors) are medications prescribed by a doctor that is intended to lower blood sugar in persons that have Type 2 diabetes. If you or a loved have experienced pain and difficulties after taking SGLT2 Inhibitors, you should consult with a skilled dangerous drugs and devices attorney. Experienced SGLT2 Inhibitors lawyers are prepared to investigate your matter and diligently pursue any and all compensation you may be entitled to.
Contracting diabetic ketoacidosis can be deadly. When someone’s body cells cannot get the sugar they require for energy, then diabetic ketoacidosis occurs. When the body is depleted of vital sugars, it begins to break down muscle and fat for energy, and ketones are released into the blood stream. Thereafter, what results is too much acid in the blood. Diabetic ketoacidosis can cause brain swelling, diabetic coma, and even death.
The Food and Drug Administration (FDA) approved of these drugs for the purpose of lowering patients’ blood sugar, making the kidneys remove sugar from the body by urination. The following is a list of available SGLT2 Inhibitors:
The following is a list of available SGLT2 Inhibitors:
Manufacturers of SGLT2 Inhibitors failed to properly warn doctors and patients about all of the serious risks associated with diabetic ketoacidosis. In addition, manufacturers failed to disclose anything concerning the risks involved with SGLT2 Inhibitors. It is important to reach out to an SGLT2 inhibitors lawyer as soon as someone suspects negligence or device failure.
Further negligent conduct includes the manufacturer’s failure to conduct appropriate testing before the products were placed on the market. Such negligent conduct demands that the manufacturers be held accountable for their wrongdoings.
If you happened to take SGLT2 Inhibitors and have experienced adverse effects and/or have developed diabetic ketoacidosis, you should consult with an experienced SGLT2 Inhibitors lawyer right away. You should not have to suffer the burden of high medical bills on top of emotional and financial hardship. Even though the FDA published reports concerning diabetic ketoacidosis, many medical professionals and patients remain unaware of the harms connected with these drugs. The experienced SGLT2 lawyers at our firm are prepared to diligently and zealously seek the damages that you are entitled to.
Charles E. Boyk Law Offices, LLC